New combo aims to shrink tough breast tumors before chemo
NCT ID NCT06353997
First seen Nov 19, 2025 · Last updated May 05, 2026 · Updated 18 times
Summary
This study tests whether adding an experimental drug (INBRX-106) to an approved immunotherapy (pembrolizumab) can shrink tumors in people with stage II or III triple-negative breast cancer before they start standard chemotherapy. About 12 adults with measurable tumors will receive two cycles of the combo, then continue with usual care. The goal is to see if this approach improves response and makes surgery more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ellison Institute of Technology (EITM)
RECRUITINGLos Angeles, California, 90064, United States
Contact Phone: •••-•••-••••
-
Providence Portland Cancer Institute - Franz Clinic
RECRUITINGPortland, Oregon, 97213, United States
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
-
Providence St. Vincent Medical Center
RECRUITINGPortland, Oregon, 97225, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Swedish Cancer Institute
NOT_YET_RECRUITINGSeattle, Washington, 98104, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.